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OUNCTIONAL EXPRESSION OF TWO SYSTEM A GLUTAMINE
RANSPORTER ISOFORMS IN RAT AUDITORY BRAINSTEM
EURONS
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bstract—Glutamine plays multiple roles in the CNS, includ-
ng metabolic functions and production of the neurotransmit-
ers glutamate and GABA. It has been proposed to be taken
p into neurons via a variety of membrane transport systems,
ncluding system A, which is a sodium-dependent electro-
enic amino acid transporter system. In this study, we inves-
igate glutamine transport by application of amino acids to
ndividual principal neurons of the medial nucleus of the
rapezoid body (MNTB) in acutely isolated rat brain slices. A
lutamine transport current was studied in patch-clamped
eurons, which had the electrical and pharmacological prop-
rties of system A: it was sodium-dependent, had a non-
eversing current-voltage relationship, was activated by pro-
ine, occluded by N-(methylamino)isobutyric acid (MeAIB),
nd was unaffected by 2-aminobicyclo-[2.2.1]-heptane-2-car-
oxylic acid (BCH). Additionally, we examined the expression
f different system A transporter isoforms using immunocy-
ochemical staining with antibodies raised against system A
ransporter 1 and 2 (SAT1 and SAT2). Our results indicate
hat both isoforms are expressed in MNTB principal neurons,
nd demonstrate that functional system A transporters are
resent in the plasma membrane of neurons. Since system A
ransport is highly regulated by a number of cellular signaling
echanisms and glutamine then goes on to activate other
athways, the study of these transporters in situ gives an
ndication of the mechanisms of neuronal glutamine supply
s well as points of regulation of neurotransmitter produc-
ion, cellular signaling and metabolism in the native neuronal
nvironment. © 2009 IBRO. Published by Elsevier Ltd.
ey words: Slc38a1, Slc38a2, SAT1, SAT2, SNAT1, SNAT2.
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bbreviations: APV, DL-2-amino-5-phosphonopentanoic acid; BCH,
-aminobicyclo-[2.2.1]-heptane-2-carboxylic acid; DL-TBOA, DL-threo-
-benzyloxyaspartate; EAAT, excitatory amino acid transporter; GST,
lutathione-S-transferase; I/V, current–voltage; Igln, glutamine-induced
urrent; Ipro, proline-induced current; MeAIB, N-(methylamino)isobutyric
cid; MK801, dizocilpine maleate; MNTB, medial nucleus of the trapezoid
ody; NBQX, 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-
ulfonamide; SAT1, system A transporter 1; SAT2, system A trans-
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orter 2; TCA, tricarboxylic acid; TTX, tetrodotoxin; VGLUT, vesicular
lutamate transporter.
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Open access under CC BY licelutamine is the most abundant amino acid in the intersti-
ial fluid of the CNS, with a concentration in the range of
.2–0.5 mM (Jacobson et al., 1985; Reichel et al., 1995;
anamori and Ross, 2004), which is over an order of
agnitude higher than any other amino acid. It is not
nown to have any direct neurotransmitter action, but does
lay several important roles within the CNS including pro-
uction of proteins, pyrimidine nucleotides, excitatory and
nhibitory neurotransmitters and tricarboxylic acid (TCA)
ycle intermediates. The intracellular glutamine concentra-
ion is thought to be in the millimolar range, and transport
nto neurons occurs against a substantial concentration
radient, which requires energy-dependent transport pro-
eins (Erecinska and Silver, 1990).
The main transport systems for glutamine are systems
, ASC, B0, B0,, b0,, L, N, and yL (reviewed by Bode,
001; Broer, 2008). Systems ASC, b0,, L and yL are
bligate exchangers, swapping internal and external
mino acids across the plasma membrane. In contrast,
ystems A, B0, and B0, use the energy derived by the
odium gradient to power the uptake of amino acids in an
lectrogenic manner, without counter-transporting another
mino acid. System N co-transports sodium and counter-
ransports a proton, resulting in a transport process that is
lose to energetic equilibrium and can mediate the uptake
r release of amino acids under physiological conditions
Chaudhry et al., 1999; Broer et al., 2002). Glutamine
ransporter expression in the CNS has been observed for
ystem A isoforms SAT1 (also called SA2, SNAT1, NAT2,
lnT and ATA1: Varoqui et al., 2000; Wang et al., 2000;
haudhry et al., 2002b; Melone et al., 2004) and SAT2
also called SA1, SNAT2 and ATA2: Reimer et al., 2000;
ugawara et al., 2000a; Yao et al., 2000; Gonzalez-
onzalez et al., 2005; Melone et al., 2006; Jenstad et al.,
009); system ASC (ASCT2: Broer et al., 1999; Dolinska et
l., 2004; Yamamoto et al., 2004); system B0 (B0AT2:
noue et al., 1996; Takanaga et al., 2005; Broer et al.,
006); system B0, (ATB0,: Sloan and Mager, 1999);
ystem b0, (rBAT/b0,AT: Bertran et al., 1992; Tate et al.,
992; Wells and Hediger, 1992); system L (LAT1 and
AT2: Kanai et al., 1998; Rossier et al., 1999; Segawa
t al., 1999); system N (SN1/SNAT3 and SN2/SNAT5:
haudhry et al., 1999, 2001; Nakanishi et al., 2001; Boul-
and et al., 2002, 2003; Cubelos et al., 2005) and system
L (yLAT2: Broer et al., 2000).
As most studies use radiolabelled substrates to study
he properties of transport systems in bulk tissue or cul-
ured cells, the cellular localization and functional proper-
ies of these different transporters in vivo is uncertain. To
nse.
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A. Blot et al. / Neuroscience 164 (2009) 998–1008 999nvestigate glutamine transport in individual, identified neu-
ons in their native physiological environment, we recorded
mino acid-induced transporter currents using whole-cell
atch-clamping in acutely isolated rat brain slices. In situ
ecordings were made from principal neurons in the medial
ucleus of the trapezoid body (MNTB), which are neurons
n the auditory brainstem that receive mainly excitatory
lutamatergic input, and release glycine, GABA and gluta-
ate at synapses in the adjacent medial and lateral supe-
ior olives (MSO and LSO; Spangler et al., 1985; Adams
nd Mugnaini, 1990; Bledsoe et al., 1990; Chaudhry et al.,
998; Gillespie et al., 2005). These cells have a spherical
ell body with only a small dendritic tree (Smith et al., 1998;
eao et al., 2008), which allows for precise recording of
omatic currents and eliminates artifacts due to dendritic
ltering (Williams and Mitchell, 2008). The astrocytes sur-
ounding the principal neurons in the MNTB have been
hown to strongly express the system N transporters SN1
nd SN2 (Boulland et al., 2002; Cubelos et al., 2005),
hich are thought to be responsible for the export of glu-
amine from the glial compartment (Chaudhry et al., 1999).
ystem N and system A transporters in adjacent cells have
een proposed to form a system N–system A shuttle
Chaudhry et al., 2002a; Gammelsaeter et al., 2009; Jen-
tad et al., 2009), which would transfer glutamine from glia
o neurons. In support of this hypothesis, our electrophys-
ological and immunocytological data show that MNTB
rincipal neurons express functional system A glutamine
ransporters on their soma. This provides a valuable in-
ight into the possible mechanisms that these neurons
mploy for amino acid and neurotransmitter metabolism.
EXPERIMENTAL PROCEDURES
lice preparation
rain slices were obtained from 10 to 15 day old Wistar rats, killed
y decapitation in accordance with the UK Animals (Scientific
rocedures) Act 1986. All animal experiments were approved by
he relevant local authorities (University of Cambridge, UK and
niversity of Oslo, Norway), and every effort was taken to reduce
he number of animals used and to minimize any suffering. Brains
ere quickly removed into a solution at approximately 0 °C con-
aining (in mM) 250 sucrose, 2.5 KCl, 10 glucose, 1.25 NaH2PO4,
6 NaHCO3, 4 MgCl2, 0.1 CaCl2; gassed with 95% O2 5% CO2
pH 7.4). Transverse brainstem slices, approximately 150 m
hick, were cut using an Integraslice 7550PSDS (Campden Instru-
ents, Loughborough, UK), and slices were placed in an incuba-
ion chamber maintained at 37 °C for half an hour, before being
llowed to cool to room temperature and used within the next 6 h.
he incubation chamber contained artificial cerebrospinal fluid
aCSF), which comprised (in mM) 125 NaCl, 2.5 KCl, 10 glucose,
.25 NaH2PO4, 26 NaHCO3, 1 MgCl2, 2 CaCl2; gassed with 95%
2 5% CO2 (pH 7.4).
lectrophysiological recording
NTB neurons were visualized with infrared differential interfer-
nce contrast (IR–DIC) optics on a Nikon E600FN microscope
Nikon Corporation, Tokyo, Japan) with a 60, numerical aperture
.0, water immersion, fluor lens. Slices were perfused at a rate of
pproximately 1 ml/min with aCSF (as above) at a temperature
f 31–35 °C. In all experiments, except for Fig. 4A–C, a cocktail of
hannel inhibitors was added to the recording solution, contain- ing (in M) 40 dl-2-amino-5-phosphonopentanoic acid (APV), 10
izocilpine maleate (MK801), 10 bicuculline, 1 strychnine, 1 TTX
tetrodotoxin) and 20 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-
f]quinoxaline 7-sulfonamide (NBQX). In the experiments re-
orded in 0 mM sodium solution (Fig. 3), NaCl and NaHCO3 were
eplaced by choline chloride and choline bicarbonate, respec-
ively, and NaH2PO4 was replaced by KH2PO4 (with a correspond-
ng reduction in KCl concentration and increase in choline chloride
oncentration to balance the other ions). Whole-cell patch-clamp
ecordings were made from MNTB cells using thick-walled glass
ipettes (GC150F-7.5; Harvard Apparatus, Edenbridge, Kent, UK)
ith a HEKA EPC-10 double amplifier and Patchmaster software
HEKA Elektronik Dr. Schulze GmbH; Lambrecht/Pfalz, Ger-
any). The intracellular solution contained (in mM) 110 Cs-meth-
nesulfonate, 40 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic
cid (HEPES), 10 tetraethylammonium chloride (TEA), 5 Na2-
hosphocreatine, 20 sucrose, 0.2 ethylene glycol-bis(2-aminoeth-
lether)-N,N,N=,N=-tetraacetic acid (EGTA), 2 MgATP, 0.5
aGTP, and 8 M CaCl2 (pH 7.2 with 10 mM CsOH). A mea-
ured liquid junction potential of 3 mV was not corrected for.
ecording pipette open-tip resistances were 5–8 M and whole-
ell access resistances were 30 M. Lucifer Yellow (0.05%)
as added to the internal solution to allow confirmation of the post
ynaptic recording site by fluorescent imaging following the com-
letion of the experiment. MNTB cells were voltage-clamped at
70 mV (unless stated) and currents were filtered at 10 and 2.9
Hz, and digitized at 25 kHz. Glutamine (or other amino acids)
ere dissolved in the relevant external solution and applied by
ressure ejection (5–10 p.s.i.) from a patch pipette (as above,
pen tip resistance 4–6 M) using a Picospritzer II (General
alve, Fairfield, NJ, USA). Puff applications were repeated at 30 s
ntervals. When applying two different glutamine concentrations,
r glutamine in different external solutions, two puffer pipettes
ere used. The pipettes were a pair pulled from one piece of glass
nd therefore had the same tip diameter, were attached to the
ame pressure source and were placed equidistant from the cell.
mmunostaining
ale Wistar rats, 200–300 g, were anesthetized with pentobarbi-
al and subjected to transcardial perfusion fixation with 4% para-
ormaldehyde in 0.1 M sodium phosphate buffer pH 7.4. The
rains were dissected out and kept in fixative over night. 40–50
m thick coronal sections were cut by a vibratory microtome.
mmunoperoxidase staining was done as described previously
Chaudhry et al., 1998; Boulland et al., 2004). Briefly, free-floating
ections were treated with 1 M ethanolamine (pH 7.4), followed by
ncubation with 1% H2O2 in phosphate-buffered saline (PBS). The
ections were incubated in solution of 10% fetal bovine serum and
.1% NaN3 in buffer A (0.3 M NaCl, 0.1 M Tris-HCl pH 7.4, 0.05%
riton X-100) prior to incubation with the primary antibodies in the
ame solution. Following incubation in biotinylated secondary an-
ibodies and the streptavidin-biotinylated horseradish peroxidase
omplex, the immunoreaction was demonstrated by addition of
,3=-diaminobenzidine (0.5 mg/ml) in PBS activated by H2O2.
The affinity-purified antibodies against SAT1 and SAT2 have
een characterized and were used as described previously (Bun-
up et al., 2008; Jenstad et al., 2009). SAT1 was used at a final
oncentration of 1 g/ml, while SAT2 was used at a concentration
f 10 g/ml. The specificity of the immunoreaction was confirmed
y pre-incubating the antibodies with the corresponding glutathi-
ne-S-transferase (GST) fusion protein (30–100 g) used for
mmunization of the rabbits.
For fluorescent immunocytochemistry, 13–14 day old rats
ere used and stained as previously described (Billups, 2005).
AT1 and SAT2 antibodies (as above) were used at 0.5 and 0.25
g/ml respectively, and secondary fluorescent antibodies (Alexa
luor 488, 2 g/ml; Invitrogen, Carlsbad, CA, USA) were visual-
zed with a confocal microscope (Leica SP5; Leica Microsystems
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A. Blot et al. / Neuroscience 164 (2009) 998–10081000MS GmbH, Mannheim, Germany). Tissue was mounted in
ectashield with DAPI (4=,6-diamidino-2-phenylindole; Vector
aboratories, Burlingame, CA, USA) to label nuclei for positive
dentification of MNTB cells.
ata analysis
urrent traces were measured using Patchmaster. For small cur-
ents (5 pA) at least three traces were averaged to improve the
ignal-to-noise ratio before measurement. Data are presented as
eanSEM and regarded as statistically significant if P0.05
sing a two-tailed paired Student’s t-tests. For multiple compari-
ons (data from Figs. 3B, 4D, 5B combined), one-way analysis of
ariance (ANOVA) was used, with Dunnett’s post test (GraphPad
rism 5.01, GraphPad Software, San Diego, CA, USA). Repeated
easures ANOVA, with Dunnett’s post test was used for the data
n Fig. 2B. Curve fitting (Fig. 1D) was performed using the least-
quared fitting algorithm implemented in SigmaPlot 10.0 (SYSTAT
oftware Inc., San Jose, CA, USA).
All chemicals were obtained from Sigma Aldrich (Gilling-
am, Dorset, UK) except: TTX (Latoxan; Valence, France) and
icuculline, NBQX, APV and MK801 (Tocris BioScience; Bris-
ol, UK).
RESULTS
lutamine induces an inward membrane current in
NTB neurons
rincipal neurons of the MNTB in rat brain stem slices
ere whole-cell patch-clamped at 70 mV and electro-
enic glutamine transport currents were stimulated by the
uff application of extracellular glutamine from either of two
lass pipettes positioned close to the cell soma (Fig 1A).
ressure ejection of 10 mM L-glutamine on to the cell
oma, produced an inward current (Igln) of 20.60.9 pA
n61; example current shown in Fig. 1B). There was no
ignificant run-down or run-up of the current magnitude
ollowing whole-cell recording, with stable recordings being
bserved for many 10s of minutes (Fig. 1C). The EC50 of
gln was estimated by applying different glutamine concen-
rations to the neurons, using the two puffer pipettes with
ne containing 10 mM glutamine and the other containing
, 5 or 20 mM. The dose–response curve is shown in Fig.
D, fitted with a Michaelis–Menten equation (Km0.940.25
M).
he glutamine current is mediated by an
lectrogenic transporter
f Igln is mediated by a transporter, external glutamine
pplication would be expected to produce an inward cur-
ent at all membrane voltages. We therefore investigated
he current–voltage (I/V) relationship of Igln by varying the
olding potential (from80 mV to40 mV in 20 mV steps)
rior to, and for the duration of, the glutamine application.
gln is reduced, but still inward, at positive membrane po-
entials, with an average magnitude of 112 pA at 40
V (Fig. 2A; n6, P0.001), i.e. a 473% reduction of the
urrent observed at 80 mV (Fig. 2B). A sample I/V
urve from one cell is show in Fig. 2C. It is evident that
does not reverse at depolarized potentials, which isgln
onsistent with an electrogenic transporter and rules out the involvement of a significant ion channel component
ig. 1. Glutamine-induced currents (Igln) are observed in whole-cell
oltage-clamped MNTB neurons. (A) Differential interference contrast
mage of a patch-clamped MNTB neuron in the brain slice. The cell (*),
atch pipette (arrow) and two puffer pipettes (arrow heads) are shown.
he scale bar is 10 m. (B): Puff-application of 10 mM glutamine for
s induces an inward membrane current of 20.60.9 pA (B1; n61)
n MNTB neurons whole-cell voltage-clamped at 70 mV. Application
f 1 mM glutamine from the other puffer pipette induces a current
09% of the current induced by 10 mM glutamine (B2; n3). (C) Plot
f the magnitude of Igln over time, demonstrating the temporal stability
f the current. (D) Dose–response curve of Igln, normalized to Igln at 10
M glutamine. The data are best-fit with a Michaelis–Menten curve
Km0.940.25 mM, Vmax1.100.04, R
20.60) shown by the solid line.o the current.
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A. Blot et al. / Neuroscience 164 (2009) 998–1008 1001he glutamine transport current is
odium-dependent
he majority of glutamine transport systems rely on the
ransmembrane sodium gradient to power the uptake pro-
ess. Consequently, we investigated the sodium-depen-
ence of Igln by removing all of the external sodium and
eplacing it with choline. Igln evoked by 10 mM glutamine
pplication in normal (152 mM) sodium was 27.11.0
A, and this was completely eliminated (0.21.0 pA;
7; P0.001) by the removal of external sodium (Fig. 3).
he total reliance of Igln on external sodium clearly dem-
nstrates the sodium-dependent nature of the glutamine
ransport process.
ontamination of the glutamine by glutamate
NTB somata express a high number of ionotropic gluta-
ate receptors, and exhibit excitatory synaptic currents of
pproximately 10 nA in magnitude (Barnes-Davies and
orsythe, 1995; Borst et al., 1995; Schneggenburger et al.,
999). The relatively high affinity of the glutamate recep-
ors (2–20 M; Patneau and Mayer, 1990) means that
ven a very small contamination of the 10 mM glutamine
olution with glutamate would cause a substantial gluta-
ate-mediated current. To guard against this possibility
e investigated the magnitude of the glutamate-induced
urrent, and inhibited it pharmacologically. To simulate a
ig. 2. I/V relationship of Igln indicates activation of a transporter. (A)
urrents elicited by 10 mM glutamine application at holding potentials
f 80 mV (A1) and 40 mV (A2). (B) Igln at 80 mV (20.31.7 pA;
6) is reduced to 15.41.4 pA at 20 mV (n6; P0.01 indicated
y the asterisks) and further reduced to 11.02.0 pA at 40 mV
n6; P0.001 indicated by the asterisks). (C) Sample current–volt-
ge relation for 1 cell showing a reduced current at positive potentials,
ut no outward current..05% glutamate contamination, as has been previously
d
tbserved with commercially sourced glutamine (Sands
nd Barish, 1989; Yamada and Rothman, 1989), 5 M
-glutamate was applied to MNTB neurons by puff appli-
ation (Fig. 4A). An inward current of 7.60.9 pA was
bserved (Fig. 4A1; n5), which was completely inhibited
to 0.10.1 pA) by a cocktail of channel inhibitors con-
aining 40 M APV, 10 M MK801, 10 M bicuculline, 1
M strychnine, 1 M TTX and 20 M NBQX (Fig 4A2 and
A3; n5; P0.001). However, in contrast, the glutamine
nduced current was not eliminated by the channel inhibi-
ors (Fig. 4B). Igln (243 pA; Fig. 4B1) was slightly re-
uced (202 pA) by the channel inhibitor cocktail (Fig.
B2; n8; P0.01). This 4 pA (17%) reduction (Fig. 4C) is
ikely to be the result of a minor (0.05%) glutamate
ontamination in the glutamine solution. All other electro-
hysiological experiments (Figs. 1–5) were performed in
he presence of this cocktail of inhibitors. Under these
onditions, Igln has neither the electrical properties (Fig. 2),
on dependence (Fig. 3) nor pharmacological profile (Fig.
) of a glutamate receptor-mediated current. A small
mount of contaminating glutamate could possibly activate
he electrogenic high-affinity excitatory amino acid transport-
rs (EAATs). The transporter EAAT1 (also called glutamate/
spartate transporter-GLAST) is strongly expressed in the
lia cells surrounding theMNTB principal cells (Renden et al.,
005). However, the EAAT3 (excitatory amino acid carrier
ig. 3. The glutamine transport current is eliminated by removing
xternal sodium ions. (A) Igln in control solution containing 152 mM
a (A1) is abolished by complete removal of Na
 from the external
edium (A2). (B) Averaged data showing that Igln is absolutely depen-
ent on the presence of external sodium (n7; P0.001 indicated by
he asterisks).
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A. Blot et al. / Neuroscience 164 (2009) 998–10081002-EAAC1) transporter, which is known to be present in the
omatodendritic compartment of post synaptic neurons
Kanai and Hediger, 1992; Rothstein et al., 1994; Danbolt,
001), is less strongly expressed in the MNTB (Renden et
l., 2005). To explore the possible involvement of these
ransporters in the observed membrane current, we ap-
lied the broad-spectrum EAAT inhibitor DL-threo-b-benzy-
oxyaspartate (DL-TBOA; Shimamoto et al., 1998). Appli-
ation of 200 M DL-TBOA had no significant effect on Igln,
hich was 14.92.4 pA in control and 14.51.8 pA in
he presence of TBOA (994% of control; Fig. 4D; n4,
	0.05). The glutamine evoked current is therefore not a
esult of activation of EAATs, either by glutamine itself or
y a small amount of contaminant glutamate.
he glutamine currents are mediated by system A
ransport activity
o elucidate which glutamine transport system is respon-
ible for generating the currents in MNTB neurons, we
nvestigated the pharmacological properties of Igln. The
wo main electrogenic, sodium-dependent, glutamine
ransporters expressed in neurons are system A and sys-
ig. 4. Glutamate receptor and transporter currents do not contribut
nduces an inward current (A1; 7.60.9 pA; n5), which is completel
f ion channel inhibitors containing 40 M APV, 10 M MK801, 10
lutamate, GABA and glycine receptor inhibitors in the bathing solut
educes Igln to 202 pA (C2; n8; P0.01). All other electrophysio
nhibitors. (C): The fractional reduction of Igln by the channel inhibito
ontamination current. (D): Application of 200 M DL-TBOA, to inhibit
hannel inhibitors. Igln in control was 14.92.4 pA and in TBOA waem B0. System A transporters are characteristically sen- sitive to the competitively transported amino acid analogue
-(methylamino)isobutyric acid (MeAIB; Christensen et al.,
965), and are unaffected by 2-aminobicyclo-[2.2.1]-hep-
ane-2-carboxylic acid (BCH; Christensen, 1990). In con-
rast, system B0 transporters are competitively inhibited by
CH, but are unaffected by MeAIB (Sloan and Mager,
999; Broer et al., 2004, 2006). We therefore examined
eAIB-induced currents and Igln in the presence of MeAIB
r BCH (Fig. 5). Puff application of 10 mM MeAIB induced
n inward current of 7.40.8 pA (Fig. 5A2), which is
42% of Igln (Fig. 5B; n4; P0.001), consistent with
eAIB being a transported substrate for this carrier with a
lower maximal transport rate. Additionally, glutamine and
eAIB can be shown to be acting on the same transporter
s the continued presence of MeAIB in the bathing solution
ccludes Igln: 10 mM MeAIB reduced Igln to 3.60.4 pA
by 803%; Fig. 5A3; n15, P0.001), and 20 mM re-
uced it to 1.00.4 pA (by 962%; Fig. 5A4; n4,
0.001). Ten millimolar BCH had no significant effect on
he current, with Igln being 15.62.1 pA (844% of con-
rol; Fig. 5A5 and B; n6, P	0.05). These results indicate
hat Igln is mediated by system A transport and not by
observed glutamine current. (A) Puff application of 5 M glutamate
ed (A2; 0.10.1 pA; n5; P0.001) by bath application of a cocktail
ulline, 1 M strychnine, 1 M TTX and 20 M NBQX. (B): Without
as 243 pA (C1; n7). Bath application of the channel inhibitors
xperiments (Figs. 1–5) were done in the presence of this cocktail of
2% (n8; P0.01 shown by the asterisks), indicating only a minor
te transporters, has no effect on Igln recorded in the presence of the
1.4 pA (994% of control; n4, P	0.05).e to the
y eliminat
M bicuc
ion, Igln w
logical e
rs is 17ystem B0.
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A. Blot et al. / Neuroscience 164 (2009) 998–1008 1003Two isoforms of the system A transporters have been
roposed to be present in neurons, SAT1 and SAT2. While
hey both transport glutamine, they differ in their transport
ates for L-proline. The proline transport rate of SAT2 is
reater than glutamine transport rate, showing an increase
n current of between 10 and 100% (Reimer et al., 2000;
haudhry et al., 2002b; Mackenzie et al., 2003). The pro-
ine transport rate for SAT1 is between 60 and 90% lower
han the glutamine transport rate (Chaudhry et al., 2002b;
ackenzie et al., 2003). By alternately applying 10 mM of
ither glutamine or L-proline via the two puffer pipettes, we
nvestigated the relative magnitude of the proline current.
he proline-induced current (Ipro) was a similar magnitude
o Igln (24.82.6 pA; 1167% of control; Fig. 5A6 and B;
12, P	0.05). MeAIB (10 mM) reduced Ipro to 5.81.7
A (by 726%; Fig. 5A6 and B; n4, P0.001), which is
omparable to the competitive inhibition of Igln. The rela-
ively large magnitude of Ipro and its inhibition by MeAIB
ndicate that at least part of Igln must be mediated by SAT2,
ut does not rule out the possibility that both SAT1 and
AT2 contribute to the glutamine current in these cells. In
ontrast to L-proline, D-proline induces a greatly reduced
urrent (2.10.9 pA; Fig. 5B; n5; P0.001), consistent
ith the stereo-specificity of system A transport (Varoqui et
ig. 5. Igln is mediated by system A transporters. (A) Compared to Igl
urrent of7.40.8 pA (A2; n4; P0.001). In the presence of 10 mM
he presence of 10 mM BCH (A5, grey trace), which inhibits B
0 transpo
A6, black trace) produces a transport current of comparable magnitude
: Normalized data showing the relative magnitude of the MeAIB indu
eduction; n15; P0.001) and 20 mM MeAIB (962%; n4; P0.00
	0.05). The L-proline-induced current is a similar magnitude to Igln, (
o the bath (n4, P0.001). D-proline induces a current that is much s
re indicated by the asterisks over the appropriate bars.l., 2000). aAT1 and SAT2 proteins are expressed in the MNTB
o further investigate which of the system A transporter
soforms contribute to Igln in the MNTB, we performed
mmunocytochemical staining using antibodies raised
gainst SAT1 and SAT2 proteins. Immunoreactivity for
oth SAT1 (Fig. 6A, C) and SAT2 (Fig. 6B, D) was de-
ected in large neuronal-like cell bodies in the MNTB,
ndicating the presence of these transporters in the princi-
al neurons. No reactivity was observed in the axons of the
rapezoid body fibers, which traverse this brain region. The
taining is abolished by preincubation of the antibodies
ith the GST fusion protein used during the immunization
f the rabbits (Figs. 6A=, B=), which confirms the specificity
f the antibodies for SAT1 and SAT2. Combined with the
lectrophysiological data, this provides strong evidence
hat both SAT1 and SAT2 contribute to the glutamine-
nduced current that we observe in these neurons.
DISCUSSION
e have shown that MNTB neurons use membrane trans-
orters to take up glutamine in a sodium-dependent and
lectrogenic manner. The current-voltage relationship re-
eals that the current induced by external glutamine is
transported system A analogue MeAIB (10 mM) induces a reduced
trace) or 20 mM MeAIB (A4, grey trace), Igln (black traces) is inhibited.
es not reduce Igln (A5, black trace). Puff-application of 10 mM L-proline
M glutamine, which is similarly inhibited by 10 mM MeAIB (grey trace).
nt (342%; n4; P0.001), Igln inhibition by 10 mM MeAIB (803%
illimolar BCH had no significant effect on Igln (164% reduction; n6;
0.05), and it is inhibited by 726% by the addition of 10 mM MeAIB
3%) than the L-proline current (n5; P0.001). P values of 0.001n (A1), the
(A3, grey
rters, do
to 10 m
ced curre
1). Ten m
n12; P	
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A. Blot et al. / Neuroscience 164 (2009) 998–10081004oltages. This is indicative of a transporter current, and
s consistent with the inward rectification observed for
ystem A transporters expressed in Xenopus oocytes or
EK293T/17 cells (Chaudhry et al., 2002b; Mackenzie et
l., 2003; Zhang and Grewer, 2007). The observed Igln is
ot an artifact of glutamate contamination of the glutamine
olution, as it does not have the pharmacology of a gluta-
ate transporter or receptor mediated current, and the
oltage dependence is inconsistent with activation of a
on-specific cation channel.
The electrical and pharmacological profile of the cur-
ent is consistent with it being mediated by system A
ransport, and excludes the involvement of all other trans-
ort systems: the glutamine current is sodium-dependent,
nlike the transport mediated by systems L (Kanai et al.,
998; Rossier et al., 1999; Segawa et al., 1999) and b0,
Bertran et al., 1992; Tate et al., 1992; Wells and Hediger,
992). Of the sodium-dependent transporters, ASCT2 (Ut-
unomiya-Tate et al., 1996; Broer et al., 1999) and yL
Broer et al., 2000) are electroneutral, so cannot contribute
o the observed current. The system N transporters SN1
nd SN2 are sodium-dependent and can be electrogenic
s a result of an uncoupled proton flux (Chaudhry et al.,
999, 2001; Broer et al., 2002). Although they are highly
xpressed in the MNTB, expression is limited to glial cells
ig. 6. Two system A transporters, SAT1 and SAT2, are localized to
he cell bodies of the principal neurons of the MNTB. Coronal sections
ere cut through the rat auditory brainstem and immunoperoxidase-
tained using affinity-purified antibodies generated against SAT1 and
AT2. (A): Strong SAT1 immunoreactivity is detected in neuron-like
ell bodies in the adult MNTB leaving the trapezoid body fibers un-
tained. (A=) This staining pattern is abolished upon preincubation of
he antibodies with the immunizing GST fusion protein. (B) SAT2
mmunoreactivity is also pronounced in the cell bodies of scattered
eurons in between trapezoid body fibers in the adult MNTB. (B=) Only
aint diffuse background staining remained in this nucleus upon pre-
ncubation of the SAT2 antibody with the GST fusion protein used to
mmunize the rabbits. C and D: Fluorescent immunocytochemical
taining of SAT1 (C) and SAT2 (D) in 13–14 day old rats, showing
trong labeling in MNTB principal cells bodies. The scale bar in all
anels is 50 m.nd they are absent from the MNTB principal neurons pBoulland et al., 2002; Cubelos et al., 2005). All of these
ransporters (L, b0,, ASCT2, yL and N) do not transport
roline and are insensitive to MeAIB. The system B0 trans-
orter B0AT2 does transport glutamine and proline in an
lectrogenic, sodium-dependent manner. However, it can-
ot be the mediator of the current we observe as B0AT2 is
nsensitive to MeAIB and is inhibited by BCH. In addition,
he transport efficiency for proline is much higher than that
or glutamine (Takanaga et al., 2005; Broer et al., 2006),
hich is contrary to our observations. The related system
0, transporter ATB0, is also an electrogenic glutamine
ransporter. However, its expression in the brain is limited,
t is sensitive to BCH and it does not transport proline
Sloan and Mager, 1999). System A is therefore the only
ransport system that fulfills the criteria of sodium-depen-
ent, electrogenic transport of glutamine and proline, in an
eAIB sensitive and BCH insensitive manner. The MeAIB
nduced current is 34% of the magnitude of Igln, which is
ery similar to the relative MeAIB current observed in
enopus oocytes expressing SAT1 (Chaudhry et al.,
002b) or SAT2 (Reimer et al., 2000; Sugawara et al.,
000a; Yao et al., 2000). In addition to system A, the
roton/amino acid transporters PAT1 and PAT2 have also
een shown to transport MeAIB (Chen et al., 2003ab;
ennedy et al., 2005), however unlike the currents that we
bserve, they are sodium-independent and not selective
or L-over D-proline (Sagne et al., 2001; Boll et al., 2002;
reden et al., 2003; Foltz et al., 2004). These results
dditionally implicate system A as the sole mediator of Igln.
Which isoforms of the system A family could be in-
olved in producing the membrane current we observe?
ystem A transporters belong to the solute carrier SLC38
ene family (Sundberg et al., 2008), three members of
hich (SLC38A1, A2 and A4) have been ascribed to sys-
em A. The SLC38A1 transporter protein (SAT1) is ex-
ressed mainly in neurons (Varoqui et al., 2000; Wang et
l., 2000; Chaudhry et al., 2002b; Mackenzie et al., 2003;
elone et al., 2004; Buntup et al., 2008) whereas the
LC38A2 protein (SAT2) is expressed in many tissues,
ncluding neurons and potentially in glia (Reimer et al.,
000; Sugawara et al., 2000a; Yao et al., 2000; Gonzalez-
onzalez et al., 2005; Melone et al., 2006; Jenstad et al.,
009). In contrast, the SLC38A4 transporter (SAT3,
NAT4 or ATA3) is exclusively located in liver, skeletal
uscle, placenta and olfactory bulb (Sugawara et al.,
000b; Hatanaka et al., 2001a; Desforges et al., 2006),
nd not in the brainstem (Sundberg et al., 2008). Our
mmunocytological data indicate the presence of two glu-
amine transporter isoforms, SAT1 and SAT2, in MNTB
eurons. This finding is supported by our electrophysiolog-
cal data, which show a proline response that is neither
ignificantly greater (as expected for SAT2) nor signifi-
antly smaller (as for SAT1) than the glutamine response.
n addition, we observe a Km for glutamine of 0.940.25
M, which lies in between the Kms observed for SAT1
0.3–0.4 mM) and SAT2 (1.7–2.3 mM) when expressed in
enopus oocytes (Yao et al., 2000; Chaudhry et al.,
002b; Mackenzie et al., 2003). The magnitude of the
roline current and intermediate glutamine affinity are con-
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A. Blot et al. / Neuroscience 164 (2009) 998–1008 1005istent with a mixture of SAT1 and SAT2 currents in our
ecordings. While membrane currents mediated by system
transporters have previously been shown in single cell
xpression systems, our study is the first to demonstrate
ystem A transporter currents recorded in neurons in situ.
What is the role of glutamine transport into neurons?
nder normal physiological conditions it is thought that
lutamine is transported out of glial cells by system N
ransport and into neurons by system A (Chaudhry et al.,
999, 2002a; Jenstad et al., 2009). A similar system
—system A glutamine shuttle has also been proposed to
ccur in the pancreas, where it may be involved in the
egulation of insulin secretion (Gammelsaeter et al., 2009).
ur current finding of SAT1 and SAT2 localization in the
rincipal neurons of MNTB surrounded by SN1 and SN2
xpressing glial processes (Boulland et al., 2002; Cubelos
t al., 2005) corroborate the complementary expression of
he system N and system A transporters seen in other
rain regions and consent with the notion that these trans-
orters work in concert to transport glutamine from glial
ells to neurons (Chaudhry et al., 2002a). Moreover, inhi-
ition of system A in vivo results in a 1.8 fold rise in the
xtracellular glutamine concentration and dramatically re-
uces the intracellular concentrations of glutamate (Kana-
ori and Ross, 2004; Jenstad et al., 2009), underlining the
mportance of system A transport in amino acid flux into
eurons (Rae et al., 2003). Since neurons lack pyruvate
arboxylase (Yu et al., 1983; Shank et al., 1985), they are
hought incapable of anaplerotic replenishment of TCA
ycle intermediates from glucose. It is therefore vital that
hey are able to import longer carbon chain molecules,
uch as glutamine, to replenish those lost through release
f neurotransmitters or through other metabolic processes.
n support of this notion, it has been observed that approx-
mately 50% of the glutamine applied to cultured neurons is
etabolized via the TCA cycle (Waagepetersen et al.,
005). Glutamine has been proposed to be directly utilized
s a precursor for the neurotransmitter glutamate, in the
lassically described glutamate–glutamine cycle (Ben-
amin and Quastel, 1972; Hamberger et al., 1979). This
as been shown to occur under physiological conditions in
he retina (Barnett et al., 2000; Poitry et al., 2000) and in
ippocampal cell culture and slices (Armano et al., 2002;
acci et al., 2002), although this hypothesis has recently
een challenged (Kam and Nicoll, 2007). Glutamine, via
he production of glutamate, is also a precursor for the
nhibitory transmitter GABA (Sonnewald et al., 1993), and
ystem A transport in this pathway has been demonstrated
o contribute to the maintenance of inhibitory synaptic
ransmission in the hippocampus (Liang et al., 2006; Fricke
t al., 2007). The MNTB neurons used in this study are
rincipally glycinergic, but also release GABA as a co-
ransmitter (Webster et al., 1990; Chaudhry et al., 1998;
otak et al., 1998; Korada and Schwartz, 1999; Smith et
l., 2000). Additionally, they have been shown to release
lutamate in a vesicular manner from their presynaptic
erminals, which is most prominent early on in develop-
ent (post-natal days 1–8), but also persists at older ages
Gillespie et al., 2005). It is therefore likely that the trans-ort of glutamine into these neurons is involved in mainte-
ance of their neurotransmitter pool. This glutamate re-
ease is mediated by the vesicular glutamate transporter
(VGLUT3), which is expressed both in the presynaptic
erminals and the MNTB somata (Boulland et al., 2004;
illespie et al., 2005). Somatodendritic expression of
GLUT3 could also mediate glutamate release as a retro-
rade messenger (Harkany et al., 2004), with a mecha-
ism that has previously been shown to be dependent on
ystem A glutamine transport into neurons (Jenstad et al.,
009).
As a consequence of its important role in amino acid
ux and cell metabolism, system A transport is noted for its
igh degree of regulation by a number of environmental
timuli (McGivan and Pastor-Anglada, 1994). These in-
lude downregulation in ischemic preconditioning (Kam-
huis et al., 2007), upregulation in response to starvation
r amino acid deprivation (Kilberg et al., 2005), subtype
ependent regulation by agents that increase cAMP (Ha-
anaka et al., 2001b), and a rapid induction of expression
f SAT1 by brain-derived neurotrophic factor (BDNF;
urkhalter et al., 2007). Glutamine that is transported into
ells (by system A; Baird et al., 2009) is also used to power
ertiary active transport of essential amino acids (such as
eucine) via system L, which then go on to activate signal-
ng pathways such as the mammalian target of rapamycin
mTOR; Baird et al., 2009; Nicklin et al., 2009). Its involve-
ent in these signaling pathways places system A at the
eart of many cellular physiological processes. Hence, our
emonstration of neuronal system A transporter currents in
itu will allow further investigation of the role that this
ransporter plays in coordinating the cellular response to
euronal activation.
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